Extrapulmonary dissemination of mycobacterium bovis but not mycobacterium tuberculosis in a bronchoscopic rabbit model of cavitary tuberculosis

Infection and Immunity

Volumn 77, Issue 2, 2009, Pages 598-603

  Nedeltchev, Gueno G ^a   Raghunand, Tirumalai R ^a,c   Jassal, Mandeep S ^a,b   Lun, Shichun ^a   Cheng, Qi Jian ^a,d   Bishai, William R ^a,b  

^a Center for Tuberculosis Research   (India)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL METABOLISM; COLONY FORMING UNIT; DOSR GENE; EXTRAPULMONARY TUBERCULOSIS; GENE EXPRESSION; HISTOPATHOLOGY; HYPOXIA; ICL GENE; INOCULATION; LUNG TUBERCULOSIS; MICROENVIRONMENT; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RABBIT; SIGC GENE; UPREGULATION; ANIMAL; BRONCHOSCOPY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; LUNG; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; REPRODUCIBILITY;

ANIMALS; BRONCHOSCOPY; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, BACTERIAL; LUNG; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; RABBITS; REPRODUCIBILITY OF RESULTS; TUBERCULOSIS, PULMONARY;

EID: 60549117313     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01132-08     Document Type: Article

References (39)

1. Behr, M. A., S- A. Warren, H. Salamon, P. C. Hopewell, A. Ponce de Leon, C. L. Daley, and P. M. Small. 1999. Transmission of Mycobacterium tuberculosis from patients smear negative acid fast bacilli. Lancet 353:444-449.
2. Blanchard, J. S. 1996. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. Annu. Rev. Biochem. 65:215-239.
3. Bloch, H., and W. Segal. 1956. Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro. J. Bacteriol. 72:132-141.
4. Canetti, G. 1955. The tubercle bacillus. Springer Publishing Company, Inc., New York, N.Y.
5. Dannenberg, A. M., Jr., and M. Sugimoto. 1976. Liquefaction of caseous foci in tuberculosis. Am. Rev. Respir. Dis. 113:257-259.
6. Dannenberg, A. M., Jr., and J. F. Tomashefski, Jr. 1988. Pulmonary diseases and disorders. McGraw-Hill, New York, N.Y.
7. Dannenberg, A. M., Jr. 1993. Immunopathogenesis of pulmonary tuberculosis. Hosp. Pract. 28:51-58.
8. Dannenberg, A. M., Jr. 2001. Pathogenesis of pulmonary Mycobacterium bovis infection: basic principles established by the rabbit model. Tuberculosis 81:87-96.
9. David, H. L. 1970. Probability of distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl. Microbiol. 20: 810-814.
10. Ehrt, S., and D. Schnappinger. 2007. Mycobacterium tuberculosis virulence: lipids inside and out. Nat. Med. 13:284-285.
11. Grosset, J. 2003. Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary. Antimicrob. Agents Chemother. 47: 833-836.
12. Helke, K. L., J. L. Mankowski, and Y. C. Manabe. 2006. Animal models of cavitation in pulmonary tuberculosis. Tuberculosis 86:337-348.
13. Lseman, M. D. 2000. A clinician's guide to tuberculosis, p. 51-62. Lippincott Williams & Wilkins, Philadelphia, PA.
14. Jasmer, R., P. Nahid, and P. C. Hopewell. 2002. Latent tuberculosis infection. N. Engl. J. Med. 347:1860-1866.
15. Karakousis, P. C, T. Yoshimatsu, G. Lamichhane, S. C. Woolwine, E, L. Nuermberger, J. Grosset, and W. R. Bishai. 2004. Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice. J. Exp. Med. 200:647-657.
16. Kramnik, L, W. F. Dietrich, P. Demant, and B. R. Bloom. 2000. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc. Nad. Acad. Sci. USA 97:8560-8565.
17. Lurie, M. B. Resistance to tuberculosis: experimental studies in native and acquired defense mechanisms. Harvard University Press. Cambridge, MA.
18. Manabe, Y. C, A. K. Kesavan, J. Lopez-Molina, C. L, Hatem, M. Brooks, R. Fujiwara, K. Hochstein, M. L. Pitt, J. Tufariello, J. Chan, D. N. McMurray, W. R. Bishai, A. M. Dannenberg, and S. Mendez. 2007. The aerosol rabbit model of TB latency, reactivation and immune reconstitution inflammatory syndrome. Tuberculosis (Edinburgh) 88:187-196.
19. McKinney, J. D., K. Höner zu Bentrup, E. J. Muñoz- Elías, A. Miczak, B. Chen, W. T. Chan, D. Swenson, J. C. Sacchettini, W. R. Jacobs, Jr., and D. G. Russel. 2000. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406:735- 738.
20. Muñoz-Elías, E. J., and J. D. McKinney. 2005. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med. 11:638-644.
21. Nardell, E. A., and W. F. Piessens. 2000. Transmission of tuberculosis, p. 215-240. In L. B. Reichman and E. S. Hershfield (ed.). Tuberculosis: a comprehensive international approach. Marcel Dekker, New York, NY.
22. Park, H. D., K. M. Guinn, M. I. Harrell, R. Liao, M. I. Voskuil, M. Tompa, G. K. Schoolnik, and D. R. Sherman. 2003. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol. Microbiol. 3:833-843
23. Ratcliffe, H. L., and W. F. Wells. 1948. Tuberculosis of rabbits induced by droplet nuclei infection. J. Exp. Med. 87:575-584.
24. Roupie, V., M. Romano, L. Zhang, H. Korf, M. Y. Lin, K. L. Franken, T. H. Ottenhoff, M. R. Klein, and K. Huygen. 2007. Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA- vaccinated and tuberculosis-infected mice. Infect. Immun. 75:941-949.
25. Rustad, T. R., M. I. Harrell, R. Liao, and D. R. Sherman. 2008. The enduring hypoxic response of Mycobacterium tuberculosis. PLoS ONE 3:el502.
26. Saini, D. K., V. Malhotra, D. Dey, N. Pant, T. K. Das, and J. S. Tyagi. 2004. DevR-DevS is a bona fide two-component system of Mycobacterium tuberculosis that is hypoxia-responsive in the absence of the DNA-binding domain of DevR. Microbiology 150:865-875.
27. Smith, D. W., and G. E. Harding. 1977. Animal model: experimental airborne tuberculosis in the guinea pig. Am. J. Pathol. 89:273-276.
28. Sun, R., P. J. Converse, C. Ko, S. Tyagi, N. E. Morrison, and W. R, Bishai. 2004. Mycobacterium Tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set. Mol. Microbiol. 52:25-38.
29. Tuberculosis Trials Consortium. 2002. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug- susceptible pulmonary tuberculosis in HIV-negative patients: a randomized clinical trial. Lancet 360:528-534.
30. Via, L. E., P. L. Lin, S. M. Ray, J. Carillo, S. S. Allen, S. Y. Eum, K. Taylor, E. Klein, U. Manujantha, J. Gonzales, E. G. Lee, S. K. Park, J. A. Raleigh, S. N. Cho, D. N. McMurray, J. L. Flynn, and E. E. Barry III. 2008. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect. Immun. 76:2333-2340.
31. Voskuil, M. I., K. C. Visconti, and G. K. Schoolnik. 2004. Mycobacterium tuberculosis gene expression during adaptation to stationary phase and lowoxygen dormancy. Tuberculosis (Edinburgh) 84:218-227.
32. Wells, W. F., and M. B. Lurie. 1941. Experimental airborne disease: quantitative natural respiratory contagion of tuberculosis. Am. J. Hyg. 34:21-41.
33. World Health Organization Stop TB Partnership. 2006. The stop TB strategy. (WHO/HTM/TB/2006.368). World Health Organization, Geneva, Switzerland.
34. Yamamura, Y., S. Yasaka, M. Yamaguchi, K. Endo, H. Iwakura, S. Nakamura, and Y. Ogawa. 1954. Studies on the experimental tuberculous cavity. Med. J. Osaka Univ. 5:187-197.
35. Yamamura, Y. 1958. The pathogenesis of tuberculous cavities. Adv. Tuberc. Res. 9:13-37.
36. Yamamura, Y., Y. Ogawa, H. Yamagata, and Y. Yamamura. 1968. Prevention of tuberculous cavity formation by immunosuppressive drugs. Am. Rev. Respir. Dis. 98:720-723.
37. Yamamura, Y., Y. Ogawa, H. Maeda, and Y. Yamamura. 1974. Prevention of tuberculous cavity formation by desensitization with tuberculin-active peptide. Am. Rev. Respir. Dis. 109:594-601.
38. Yamamura, Y., H. Maeda, Y. Ogawa, and T. Hashimoto. 1986. Experimental pulmonary cavity formation by mycobacterial components and synthetic adjuvants. Microbiol. Immunol. 30:1175-1187.
39. Yoder, M. A., G. Lamichane, and W. R. Bishai. 2004. Cavitary pulmonary tuberculosis: the Holey Grail of disease transmission. Curr. Sci. 86:74-81.